Shanghai Fosun Pharma - Unit's Drug Registration Application for Sodium Thiosulfate Injection Approved by Nmpa

Chongqing Carelife Pharmaceutical wins China approval for sodium thiosulfate injection as Fosun Pharma unit invests CNY 1.87 million

FOSUN PHARMA Subsidiary Gains Approval for Phase I Trial of HLX18 in Solid Tumors

FOSUN PHARMA's Sodium Thiosulfate Injection Receives Regulatory Approval

BRIEF-Shanghai Fosun Pharma Says Unit Got Approval From NMPA For Clinical Trial Of Lbp-Shc4

FOSUN PHARMA's HLX07 Combined with Serplulimab Injection and Chemotherapy Cleared for Clinical Trial in Advanced Squamous Non-Small Cell Lung Cancer

Shanghai Fosun Pharma - Unit Got Approval From Nmpa for Clinical Trial of Lbp-Shc4

Fosun Pharma unit MicroH Therapeutics wins China approval for LBP-ShC4 Phase I trial in androgenetic alopecia

Fosun Pharmaceutical Gets Chinese Regulator's Nod for Clinical Trials of Blood Cancer Drug

FOSUN PHARMA Subsidiary Gains Approval for Clinical Trial of FXS0683 Tablets

Fosun Pharma Industrial wins China clinical trial approval for FXS0683 tablets

Shanghai Fosun Pharma - Approval From Nmpa for Clinical Trial of Fxs0683 Tablets

Sisram Medical board approves USD11.2 million annual royalty payment caps for 2026-2028

Fosun Pharmaceutical Unit Gets Clinical Trial Approval for Cancer Drug

FOSUN PHARMA's Controlled Subsidiary Receives Clinical Trial Approval for Drug HLX316

Fosun Pharmaceutical Gets Nod for Phase I Trial of Tumor Drug Candidate; Hong Kong Shares Up 5%

FOSUN PHARMA Subsidiary Receives Approval for Phase I Clinical Trial of HLX97 in Advanced/Metastatic Solid Tumors

Shanghai Fosun Pharmaceutical (Group) Co. Ltd. held shareholder meetings

Fosun Pharma Gets Regulatory Nod for 6 Billion Yuan Bond Issue

FOSUN PHARMA Secures Regulatory Approval for Bond Offering to Professional Investors